Clinical effects of stereotactic-guided endoscopic hematoma removal combined with early systematic rehabilitation training on hypertensive intracerebral hemorrhage in the basal ganglia
10.3760/cma.j.cn341190-20221101-00871
- VernacularTitle:立体定向引导神经内镜血肿清除术联合早期系统康复训练治疗基底核区高血压脑出血的临床观察
- Author:
Xiaoyan ZOU
1
;
Xiaojun ZHONG
Author Information
1. 浙江中医药大学护理学院，杭州 310053
- Keywords:
Intracranial hemorrhage,hypertensive;
Hematoma;
Neuroendoscopes;
Craniotomy;
Punctures;
Drainage;
Image-guided;
Inflammation mediators;
Rehabilitation;
Recurre
- From:
Chinese Journal of Primary Medicine and Pharmacy
2023;30(10):1457-1461
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical effects of stereotactic-guided endoscopic hematoma removal combined with early systematic rehabilitation training on hypertensive intracerebral hemorrhage in the basal ganglia.Methods:A total of 130 patients with hypertensive intracerebral hemorrhage in the basal nucleus who received treatment in Zhejiang Veteran Hospital from June 2019 to December 2021 were included in this randomized control study. They were randomly divided into a control group and a study group ( n = 65 per group). The control group received minimally invasive hematoma puncture. The study group received stereotactic-guided neuroendoscopic hematoma removal. After surgery, early systematic rehabilitation training was carried out, and surgical indicators were recorded. The levels of serum inflammatory factors and stress factors were determined. The recurrence, death, and complications as well as prognosis of cerebral hemorrhage were recorded in each group. Results:The operative time in the study group was (85.39 ± 5.24) minutes, which was significantly longer than (64.17 ± 4.31) minutes in the control group ( t = -14.56, P < 0.001). Hematoma clearance rate in the study group was (94.66 ± 5.18) %, which was significantly higher than (76.82 ± 5.39) % in the control group ( t = -17.63, P < 0.001). At 24 hours after surgery, tumor necrosis factor-α, interleukin-1, norepinephrine, and hydrocortisone levels in the study group were (68.29 ± 5.36) ng/L, (237.62 ± 13.87) ng/L, (75.39 ± 5.82) μg/L, and (30.96 ± 2.97) μg/L, respectively, which were significantly lower than (74.61 ± 5.62) ng/L, (295.47 ± 14.69) ng/L, (91.62 ± 6.41) μg/L, and (38.25 ± 3.16) μg/L in the control group ( t = 7.95, 18.42, 16.84, 11.75, all P < 0.001). There was no significant difference in the 6-month mortality rate between the two groups ( P > 0.05). The recurrence rate of cerebral hemorrhage and the overall incidence of complications in the study group were (1.54% (1/65) and (10.77% (7/65) in the study group, respectively, which were significantly lower than 12.31% (8/65) and 27.69% (18/65) in the control group ( χ2 = 4.30, 5.99, both P < 0.05). The overall excellent and good prognosis rate within 6 months in the study group was 86.15% (56/65), which was significantly higher than 67.69% (44/65) in the control group ( χ2 = 6.24, P < 0.05). Conclusion:Compared with minimally invasive hematoma puncture and drainage surgery, stereotactic-guided neuroendoscopic hematoma removal takes longer time, but it can better effectively increase hematoma removal rate and alleviate stress and inflammatory reactions in patients with hypertensive intracerebral hemorrhage in the basal ganglia. Early systematic rehabilitation training combined with stereotactic guided neuroendoscopic hematoma removal can help reduce the risk of recurrence and complications of cerebral hemorrhage and improve prognosis.
